home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Two Research Reports OnThe Use of Gene Therapy In The Prevention And Treatment Of Prostate Cancer.

  June, 21 2006 7:38
your information resource in human molecular genetics
Two groups have published their research findings regarding the use of gene therapy in the prevention and treatment of prostate cancer.

One group, led by Dr. T. C. Thompson, used an adenoviral vector capable of efficient transduction and expression of a novel p53 target gene RTVP-1 (AdRTVP-1), together with a highly metastatic mouse prostate cancer cell line (178-2 BMA), to prepare a vaccine (Cancer Gene Therapy, Vol. 13, pp. 658–663, 2006).

The second group, headed by Dr. Z. Dong, studied the efficacy and mechanisms of adenoviral vector-mediated interferon (IFN)- gene therapy in inhibiting orthotopic growth of human prostate cancer in immune-competent mice, producing data indicating that IFN-gene therapy could be an effective alternative for the treatment of locally advanced prostate cancer and suggesting an obligatory role of Nitric Oxide in IFN- antitumoral effects in vivo (Cancer Gene Therapy, Vol. 13, pp. 676–685, 2006).

Author Contact

Dr. T. C. Thompson, Scott Department of Urology, Baylor College of Medicine, 6560 Fannin, Suite 2100, Houston, TX 77030, USA.
E-mail: timothyt@www.urol.bcm.tmc.edu

Dr. Z. Dong, Department of Internal Medicine, Hematology-Oncology Division, University of Cincinnati College of Medicine, 3125 Eden Avenue, Rm 1308, Cincinnati, OH 45267, USA.
E-mail: dongzu@ucmail.uc.edu

Abstracts available online:

Thompson paper.
Dong paper.

(C) Cancer Gene Therapy.

Posted by: Tressie Dalaya

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.